This study was conducted to evaluate the impact of low-molecular-weight heparin (LMWH) on the outcome of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia.
Falcone, M., Tiseo, G., Barbieri, G., Galfo, V., Russo, A., Virdis, A., et al. (2020). Role of Low-Molecular-Weight Heparin in Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study. OPEN FORUM INFECTIOUS DISEASES, 7(12) [10.1093/ofid/ofaa563].
Role of Low-Molecular-Weight Heparin in Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study
Farcomeni, Alessio;
2020-12-01
Abstract
This study was conducted to evaluate the impact of low-molecular-weight heparin (LMWH) on the outcome of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
ofaa563.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Copyright dell'editore
Dimensione
373.87 kB
Formato
Adobe PDF
|
373.87 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
